Roche upbeat over hepatitis drug in US
Roche, the Swiss drugs group, has signalled that it expects Pegasys, its new hepatitis drug, to quickly emerge as the leader in the all-important US market following its rapid approval by the US Food
Roche, the Swiss drugs group, has signalled that it expects Pegasys, its new hepatitis drug, to quickly emerge as the leader in the all-important US market following its rapid approval by the US Food